SCHEDULE: Qiming Entities Report Stake in VOR BIOPHARMA INC.

Qiming Venture Partners entities report beneficial ownership of over 5% of VOR BIOPHARMA INC. common stock as of March 31, 2026.

Summary

• Qiming Venture Partners VIII-HC, L.P. beneficially owns 1,089,767 shares of VOR BIOPHARMA INC. common stock, representing 2.0% of the class.
• Qiming Venture Partners VIII Investments, LLC beneficially owns 910,172 shares of VOR BIOPHARMA INC. common stock, representing 1.7% of the class.
• Qiming GP VIII, LLC beneficially owns 910,172 shares of VOR BIOPHARMA INC. common stock, representing 1.7% of the class.
• Qiming GP VIII-HC, LLC beneficially owns 1,089,767 shares of VOR BIOPHARMA INC. common stock, representing 2.0% of the class.
• The total outstanding shares of VOR BIOPHARMA INC. common stock as of March 31, 2026, were 54,185,582.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership by investment entities and does not contain operational or financial performance updates.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that this Schedule 13G filing indicates significant investment positions held by venture capital entities in the biopharmaceutical sector, a common occurrence as firms build stakes in emerging companies.

Stakeholder Impact

• Shareholders: The filing provides transparency on significant ownership stakes, which can influence market perception and trading activity.

Key Dates

Keywords

VOR BIOPHARMA INC., Schedule 13G, Qiming Venture Partners, beneficial ownership, common stock, SEC filing, Cayman Islands